Reversal of Angiogenic Growth Factor Upregulation by Revascularization of Lower Limb Ischemia
- 1 January 2002
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (1) , 67-72
- https://doi.org/10.1161/hc0102.101360
Abstract
Background— Tissue kallikrein (tK) and vascular endothelial growth factor (VEGF) are potent angiogenic agents. Upregulation of tK or VEGF was documented in animal models of acute ischemia, yet it r...Keywords
This publication has 14 references indexed in Scilit:
- Novel Roles of Kallistatin, a Specific Tissue Kallikrein Inhibitor, in Vascular RemodelingBiological Chemistry, 2001
- Serial Changes in Serum VEGF and HGF in Patients with Acute Myocardial InfarctionCardiology, 2000
- Differences in myocardial and peripheral VEGF and KDR levels after acute ischemiaThe Annals of Thoracic Surgery, 2000
- Upregulation of bradykinin B1-receptor expression after myocardial infarctionBritish Journal of Pharmacology, 2000
- Expression of vascular endothelial growth factor in patients with acute myocardial infarctionJournal of the American College of Cardiology, 2000
- Up-regulation of vascular endothelial growth factor mrna and angiogenesis after transmyocardial laser revascularizationThe Annals of Thoracic Surgery, 1999
- Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJournal of Clinical Investigation, 1999
- Rescue of Diabetes-Related Impairment of Angiogenesis by Intramuscular Gene Therapy with Adeno-VEGFThe American Journal of Pathology, 1999
- Elevated levels of basic fibroblast growth factor in patients with limb ischemiaAmerican Heart Journal, 1996
- Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial CellsJournal of Biological Chemistry, 1995